LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL

Photo from wikipedia

John W. Semple Keenan Research Centre for Biomedical Science of St. Michaels Hospital; Departments of Medicine and Pathology, University of Rochester School of Medicine, Rochester, NY, USA; Canadian Blood Services;… Click to show full abstract

John W. Semple Keenan Research Centre for Biomedical Science of St. Michaels Hospital; Departments of Medicine and Pathology, University of Rochester School of Medicine, Rochester, NY, USA; Canadian Blood Services; Departments of Physiology and Anesthesia, University of Toronto; Department of Anesthesia and Pain Medicine, Hospital for Sick Children; Department of Pharmacology, University of Toronto; Department of Medicine, University of Toronto; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada and Division of Haematology and Transfusion Medicine, Lund University, Lund, Sweden E-mail: [email protected]

Keywords: medicine; university chicago; toronto department; university; university toronto

Journal Title: British Journal of Haematology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.